Bionic chip inserted into retina restores partial sight to 88-year-old woman
Image credit: Moorfields Eye Hospital NHS Foundation Trust
An 88-year old woman who had lost her sight in one eye has become the first person in the UK to detect signals in her blind left eye thanks to a “revolutionary” new implant.
The woman is the first UK patient to receive the new device as part of a Europe-wide clinical trial. It offers people with geographic atrophy (GA), the most common form of dry age-related macular degeneration (AMD), the hope of regaining some of their lost sight.
The procedure involves inserting a 2mm wide microchip under the centre of a patient’s retina, by surgically creating a trapdoor into which the chip is posted.
The patient uses special glasses, containing a video camera that is connected to a small computer attached to their waistband. The chip captures the visual scene projected by the glasses and transmits this to the computer.
Artificial intelligence (AI) algorithms process this information and instruct the glasses to focus on what they perceive to be the main object in the image. The glasses project this image as an infra-red beam through the eye to the chip, which converts this into an electrical signal.
This signal passes through the retinal cells and optical cells into the brain, where it is interpreted as if it were natural vision.
Four to six weeks after being inserted, this implant is tested by switching the chip on, and at this stage the patient should be able to see a signal. They then go through a rehabilitation programme to learn how to use the vision they have been given. After this, patients are potentially able to recognise words when they couldn’t before.
It is being trialled with patients who have lost their vision in an eye because of GA. This condition is progressive and currently has no treatment. 12 per cent of those over 80 will be affected by dry AMD, while GA affects 6.7 per cent of over 80s.
The 88-year-old woman, who has seven children and eight grandchildren, was the first UK patient to benefit from this implant.
She said: “Losing the sight in my left eye through dry AMD has stopped me from doing the things I love, like gardening, playing indoor bowls and painting with watercolours. I am thrilled to be the first to have this implant, excited at the prospect of enjoying my hobbies again and I truly hope that many others will benefit from this, too.”
Mahi Muqit, consultant vitreoretinal surgeon at Moorfields Eye Hospital, added: “This ground-breaking device offers the hope of restoration of sight to people suffering vision loss due to dry AMD. The success of this operation, and the evidence gathered through this clinical study, will provide the evidence to determine the true potential of this treatment.”
Sign up to the E&T News e-mail to get great stories like this delivered to your inbox every day.